Latest News

The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.

Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.

Topline phase 2 data showed single-dose ABCL635 reduced moderate-to-severe vasomotor symptom frequency by 83% at week 4.

FDA acceptance starts review of clesrovimab for second-season RSV prevention in high-risk children younger than 2 years.

Fendrick considers the current state of colorectal cancer screening in the US, emphasizing limited colonoscopy capacity and patient preferences for at-home tests.

The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.

Community health workers and population health screening tactics help primary care teams address SDOH and reduce hospital utilization.

The FDA has approved mFLUSIVA, Moderna's first mRNA flu vaccine, for adults 50 and older ahead of the 2026-2027 season.